Skip to main content
OpenTrials
Completed

NCT Number: NCT00561600

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

The primary objective of this investigation is to evaluate the clinical and radiographic outcomes of the ASR™-XL Acetabular Cup System compared to the Pinnacle™ Acetabular Cup with a 28mm or 36mm ULTAMET™ metal insert.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Desert Orthopaedics, Rancho Mirage, California, United States

Loading trial locations.

About this study

The purpose of this clinical investigation is to gather sufficient clinical and radiographic data to permit valid scientific comparisons between treatment and control group outcomes. The treatment group/device for this study is the ASR™-XL Acetabular Cup System, and the control group/device is the Pinnacle™ Cup System w/ the 28mm or 36mm ULTAMET™ metal liner. The study objective will be achieved by way of treatment group selection, treatment administration, and management of participating study Subjects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is able to or capable of providing consent to participate in the clinical investigation.
  • Subject is between the ages of 20-75 years, inclusive.
  • Subject requires a cementless, primary total hip arthroplasty for non-inflammatory degenerative joint disease (NIDJD).
  • Subject has sufficient bone stock for the hip replacement device.
  • Subject is a suitable candidate for the devices specified in the clinical investigation plan and is willing to be randomized to either cup system device.

Exclusion criteria

  • Subject, in the opinion of the Investigator, has an existing condition that would compromise his/her participation and follow-up in this investigation.
  • Subject with a known allergy to metal (e.g. jewelry).
  • Subject has inflammatory arthritis (e.g. rheumatoid arthritis).
  • Subject has active or recent joint sepsis.
  • Subject with marked atrophy or deformity in the upper femur.
  • Subject with a neuromuscular disease where the loss of musculature would affect functional outcome.
  • Subject, in the opinion of the Clinical Investigator, has a history of chronic renal insufficiency (e.g. dialysis).
  • Subject is receiving systemic steroid therapy, excluding inhalers or intra-capsular injections, within 3 months prior to surgery.
  • Subject with known, active metastatic or neoplastic disease.
  • Subject is known to be pregnant, a prisoner, mentally incompetent, and or alcohol or drug abuser.
  • Subject is currently involved in any personal injury litigation, medical legal or worker's compensation claims.

Treatment and study plan

ASR™-XL Modular Acetabular Cup System

Device

The ASR™-XL Modular Acetabular Cup System treatment device is comprised of a metal acetabular cup, a unipolar femoral head and a taper sleeve adapter.

Other names: Acetabular cup replacement

Pinnacle™ acetabular shell

Device

The Pinnacle™ shells are cementless, titanium alloy cups with Porocoat® porous coating and HA DuoFix™ coating. There are various different liners available for use with the Pinnacle™ Acetabular Cup System. For the purpose of this investigation, the CoCrMo ULTAMET® 28mm or 36 mm metal liners will be used.

Other names: Acetabular cup replacement

Primary outcomes

  1. Composite Success Based Upon Harris Hip Score, Radiographic and Survivorship Outcomes

    Time frame: 24-month interval.

    "Composite success: 1) Revision free (life of study) 2) No evidence of radiographic failure (life of study) 3) Harris Hip score => 80 at 24 months"

Secondary outcomes

  1. T-Test of Harris Hip Total Score Means at 24 Months

    Time frame: 24 months

    T-Test of Harris Hip total score means at 24 months

  2. Harris Hip Pain Sub Score at 24 Months

    Time frame: 24 months

    Mean Harris Hip Pain sub score

  3. Harris Hip Function Score at 24 Months

    Time frame: 24 months

    Mean Harris Hip Function sub score at 24 months

  4. Analysis of Metal Ion Release - Serum Cobalt

    Time frame: Pre-operative

    Serum Cobalt

  5. Analysis of Metal Ion Release - Serum Chromium

    Time frame: pre-operative

    Serum Chromium

  6. Analysis of Metal Ion Release - Erythrocyte Cobalt

    Time frame: pre-operative

    Erythrocyte cobalt

  7. Analysis of Metal Ion Release - Erythrocyte Chromium

    Time frame: Pre-operative

    Erythrocyte Chromium

  8. Analysis of Metal Ion Release - Serum Cobalt

    Time frame: 4 months post-operative

    Serum Cobalt

  9. Analysis of Metal Ion Release - Serum Chromium

    Time frame: 4 months post operative

    Serum Chromium

  10. Analysis of Metal Ion Release - Erythrocyte Cobalt

    Time frame: 4 months post-operative

    Erythrocyte Cobalt

  11. Analysis of Metal Ion Release - Erythrocyte Chromium

    Time frame: 4 months post-operative

    Erythrocyte Chromium

  12. Analysis of Metal Ion Release - Serum Cobalt

    Time frame: 12 months post-operative

    Serum Cobalt

  13. Analysis of Metal Ion Release - Serum Chromium

    Time frame: 12 Months

    Serum Chromium

  14. Analysis of Metal Ion Release - Erythrocyte Cobalt

    Time frame: 12 Months

    Erythrocyte Cobalt

  15. Analysis of Metal Ion Release - Erythrocyte Chromium

    Time frame: 12 months

    Erythrocyte Chromium

  16. Analysis of Metal Ion Release - Serum Cobalt

    Time frame: 24 months

    Serum Cobalt

  17. Analysis of Metal Ion Release - Serum Chromium

    Time frame: 24 months

    Serum Chromium

  18. Analysis of Metal Ion Release - Erythrocyte Cobalt

    Time frame: 24 months

    Erythrocyte Cobalt

  19. Analysis of Metal Ion Release - Erythrocyte Chromium

    Time frame: 24 months

    Erythrocyte Chromium

  20. Analysis of Metal Ion Release - Serum Cobalt

    Time frame: 36 months

    Serum Cobalt

  21. Analysis of Metal Ion Release - Serum Chromium

    Time frame: 36 months

    Serum Chromium

  22. Analysis of Metal Ion Release - Erythrocyte Cobalt

    Time frame: 36 months

    Erythrocyte cobalt

  23. Analysis of Metal Ion Release - Erythrocyte Chromium

    Time frame: 36 months

    Erythrocyte chromium

  24. Analysis of Metal Ion Release - Serum Cobalt

    Time frame: 48 months

    Serum Cobalt

  25. Analysis of Metal Ion Release - Serum Chromium

    Time frame: 48 months

    Serum Chromium

  26. Analysis of Metal Ion Release - Erythrocyte Cobalt

    Time frame: 48 months

    Erythrocyte Cobalt

  27. Analysis of Metal Ion Release - Erythrocyte Chromium

    Time frame: 48 months

    Erythrocyte chromium

Sponsors and collaborators

Lead sponsor

DePuy Orthopaedics

Industry

Registry information

Official study title

A Randomized, Prospective, Comparative, Multi-Center Clinical Evaluation of the DePuy ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System Study

Acronym: ASR

Important dates

Study start
2006
Primary completion
2012
Study completion
2012
First posted
Nov 21, 2007
Registry last updated
Aug 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.